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Worldwide Occurrence of 
Beijing/W Strains of 
Mycobacterium tuberculosis: 
A Systematic Review
Judith R. Glynn,* Jennifer Whiteley,* Pablo J. Bifani,† Kristin Kremer,‡ 
and Dick van Soolingen‡
Strains of the Beijing/W genotype family of Mycobacterium tuberculosis have caused large outbreaks of
tuberculosis, sometimes involving multidrug resistance. This genetically highly conserved family of M.
tuberculosis strains predominates in some geographic areas. We have conducted a systematic review of
the published reports on these strains to determine their worldwide distribution, spread, and association
with drug resistance. Sixteen studies reported prevalence of Beijing strains defined by spoligotyping;
another 10 used other definitions. Beijing strains were most prevalent in Asia but were found worldwide.
Associations with drug resistance varied: in New York, Cuba, Estonia, and Vietnam, Beijing strains were
strongly associated with drug resistance, but elsewhere the association was weak or absent. Although few
reports have measured trends in prevalence, the ubiquity of the Beijing strains and their frequent associa-
tion with outbreaks and drug resistance underline their importance.
n the early 1990s, a multidrug-resistant Mycobacterium
tuberculosis strain was identified in New York (1). This
strain, designated “W,” which was associated with large insti-
tutional outbreaks of tuberculosis (TB) and many deaths, was
later identified in other parts of the United States (2,3). In
1995, a large proportion of the M. tuberculosis strains in the
Beijing area of China was reported to have mutually highly
similar multi-banded IS6110 restriction fragment-length poly-
morphism (RFLP) patterns; these “Beijing” strains were also
present in many other populations (4). 
The New York City multidrug-resistant “W” strain was, in
the second half of the 1990s, recognized as a member of the
“Beijing” genotype family of M. tuberculosis strains (5–7).
The W strain is recognized by a specific IS6110 fingerprint
pattern, by multiplex polymerase chain reaction (PCR) tar-
geted at specific insertions, or both (2,3). W family strains
have IS6110 patterns closely related to that of W, although the
degree of similarity in different studies has not always been
specified. Beijing strains, including the W variants, have an
insertion of IS6110 in the genomic dnaA-dnaN locus (5,7). All
W family strains have a characteristic spoligotype that is
shared with the whole Beijing family of strains and seems to
be specific for this family (4,8,9). Spoligotyping is based on
DNA polymorphism in the direct repeat region, and “Beijing”
spoligotypes only contain spacers 35–43.
The combination of a widespread family of strains and, in
some situations, the association with multidrug resistance has
led to concern that these strains may be spreading and may
have a predilection for acquiring drug resistance. Many recent
studies have recorded “Beijing-like” or “W-like” strains. We
have conducted a systematic review of published reports to
assess how widespread the family of strains is, whether there
is any evidence that it is spreading, and whether it is associated
with drug resistance. 
Methods
Relevant studies were identified through computerized
searches of Medline (January 1, 1990–November 1, 2001) and
PubMed (January 1, 2000–November 1, 2001), manually
searching key journals, searching the Internet, and cross-
checking references with collections of articles on Beijing
strains compiled by researchers in the field. The computerized
searches used both thesaurus and free-text terms to search for
tuberculosis and any of the following: molecular epidemiol-
ogy, DNA fingerprinting, DNA fingerprint*, typing, type,
types, restriction fragment length polymorphism, RFLP, spoli-
gotyping, spoligotyp*, strain, and strains. The International
Journal of Tuberculosis and Lung Disease, its predecessor
Tuberculosis and Lung Disease, and the Journal of Clinical
Microbiology were searched manually back to January 1990.
A request for relevant articles was sent to all 32 participants in
the European Union Concerted Action project on New Gener-
ation Genetic Markers and Techniques for the Epidemiology
and Control of Tuberculosis. An Internet search, using Google,
used the term “Beijing strain tuberculosis.” The reference lists
of all included articles were searched for additional relevant
studies.
Articles were included if they contained information
allowing estimation of the proportion of TB patients included
with the Beijing or W strains. Articles were excluded if they
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were limited to a particular outbreak, if they included only
drug-resistant strains, or if <30 TB patients were included.
Identified articles were subdivided into those that used spolig-
otyping to identify Beijing family strains and those that used
other methods. Where spoligotypes were shown, estimates
based on the spoligotype were used rather than any estimate
given in the papers, using the proportion with spacers 35–43.
Studies identifying only W strains or other W-like strains with
a single IS6110 fingerprint pattern will underestimate the prev-
alence of Beijing strains, since they identify only part of the
family of strains. The method of patient selection was
recorded when stated. In all studies, any evidence of changes
over time or by age group or of any association between strain
type and drug resistance was recorded.
 Results
Five thousand nineteen articles were selected from the ini-
tial search of Medline and PubMed. The titles and abstracts of
these articles were scanned for relevant information, and 4,909
articles were rejected, leaving 110 articles for full text review.
No further articles were identified by manual searching, but
one recently published article was identified in the article col-
lections that had not yet been indexed in the databases (10).
One additional article was identified from reference list check-
ing that was published in a Vietnamese journal not indexed by
Medline, EMBASE, or Web of Science, and we have been
unable to locate it. Another article was found from an Internet
search, in an electronic journal (11). Of the 112 articles
reviewed in full, 26 fulfilled the inclusion criteria of this
review, including 16 that gave results based on spoligotyping
and several that reported results from more than one area
(Tables 1,2; Figure). Studies that described patients who were
apparently included in other reports have been excluded
(31,32).
The Beijing strain was most common in the Beijing area of
China, accounting for 92% of strains (4,12). The strain was
common in all the Asian studies (4,8,12–15,23–25) and also in
Houston, Texas (25%), and Estonia (29%) (18,20). Some
examples of the Beijing family were seen in almost all the
populations studied (Tables 1 and 2).
Two studies looked at trends over time (Table 1). In China,
the proportion of TB due to Beijing family strains in stored
specimens going back to the 1950s was similar to the propor-
tion among more recent specimens (12). In Gran Canaria, a
dramatic increase was seen from 1992 to 1996, traced to an
outbreak originating from a noncompliant patient with laryn-
geal TB (19). In studies over a short period, variations with
age can be studied as a proxy for time trends. In Vietnam,
among new cases of TB, the proportion due to Beijing strains
was 71% in those <25 years of age, decreasing to 41% in those
>55 years (p < 0.001, chi square test for trend) (14). In
Bangkok, little difference was seen with age in two studies
(15,24). In Hong Kong (13), Jakarta, Indonesia (8), and Esto-
nia (18), there was no association between age and disease due
to the Beijing strain. In New Jersey, among those with tubercu-
losis due to W-like strains, 70% of patients were <50 years old,
compared with 63% of those with other strains (p=0.2) (9). In
Gran Canaria, the median age of cases with the Beijing strain
was similar to that of all cases (19). No other studies have pre-
sented results by age.
Several studies reported associations with drug resistance
(Table 3). Some studies found high rates of drug resistance
among Beijing strains, but others found no difference in drug
resistance profiles between Beijing and the other local strains.
An association between the successful spread of Beijing
strains and BCG vaccination has been suggested (4). In
Jakarta, Indonesia (8), 26% of those with Beijing strains and
23% of other patients had a BCG scar. In Vietnam, although a
higher proportion of those with Beijing strains than with other
strains had a BCG scar, this association was no longer appar-
ent after the data were adjusted for age (14).
 Discussion
This review has confirmed the ubiquity of the Beijing fam-
ily of strains. Only a few of the smaller studies (in Martinique
and French Guiana) found no examples, and the proportion of
TB due to Beijing strains in several Asian studies was >50%.
However, studies could only be included in the review if they
mentioned the Beijing strain or strain W or presented data
showing spoligotypes. Some of the excluded studies may have
found Beijing strains but not reported them as such (33,34).
Others may have looked for Beijing strains but not reported
negative findings. The only articles identified that reported not
finding Beijing strains were studies including more than one
study site. It is not known how unusual it is for a genotype
family of M. tuberculosis to be as widespread as this. Compa-
rable data are not available for other strains, although they are
beginning to be gathered, and some other strains have also
been found in several distinct settings (35).
In many studies, the true proportion of TB attributable to
the Beijing family of strains is hard to assess. Difficulties arise
due to the variable strain definitions used and the way patients
were selected for inclusion. Spoligotyping seems to be both
sensitive and specific for the Beijing family and is also easily
compared between studies (6). Although IS6110 fingerprinting
can also be used to detect this genotype family, with results
that correlate closely with the spoligotypes, most published
studies have used narrow definitions, based on a single strain
or a few closely related strains defined by IS6110 fingerprint-
ing; such studies are thus likely to underestimate the preva-
lence of Beijing strains. Studies including drug resistance in
the definition (2) and those that appear to have defined the
strains after grouping by drug resistance (26) may also under-
estimate the prevalence. 
Some of the studies (those in the Netherlands, New Jersey,
Houston, Texas, Gran Canaria, and French Guiana and the
Caribbean islands) included information on all TB patients in
the population and thus provide reliable estimates of preva-
lence. Others were less representative, and many did not state
how the patients were selected (Table 1 and 2). Studies that
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included patients from particular hospitals may be representa-
tive of an area, but referral hospitals may be biased if they
accept a high proportion of drug-resistant or complex cases.
Similarly, convenience samples may not be representative of
the community of TB patients, particularly if the samples were
kept because they were interesting in some way (e.g., drug
resistant or from epidemiologically related cases). TB patients
in prison (10) may not have the same strains as those in the
community. Some studies included only new patients, and oth-
ers included both new patients and recurrent cases. This dis-
tinction, which was often not clear in the reports, could
influence the results if relapse rates differ between strains. 
Table 1. Prevalence of Beijing family strains in studies that have used spoligotypinga
Reference Setting Yrs Population New TB or new + old Prevalence Beijing strain N/N (%)
Asia
12 Beijing and Hebei province, 
China
1956–1960 Stored lung biopsy samples 
from pneumonectomies
? Both 9/10 (90)
1969–1970 8/9 (89)
1979–1980 18/18 (100)
1989–1990 10/12 (83)
1956–1990 45/49 (92)
4 Beijing, China 1992–1994 ? Selection method ? Both 45/49 (92)
13 Hong Kong 1998–1999 Random sample ? New 337/500 (67)
14 Ho Chi Minh City, and Hanoi, 
Vietnam
1998–1999 ? All patients New 301/563 (53)
15 Bangkok, Thailand 1999–2000 One hospital
? Selection method
? Both 90/204 (44)
8 Jakarta, Indonesia 1998–1999 Consecutive patients one clinic ? Both 31/92 (34)
Africa
16 Senegal 1994–1995 ? Selection method (all Beijing 
were relapses)
Both 8/69 (12)
Middle East
17 Fars Province and Tehran, Iran 1995–1996 All from Shiraz; 
? random for others
Both 10/97 (10)
Europe
11 Northwest region, Russia 1997–1998 ? Selection method Both 22/100 (22)
10 Azerbaijan 1995–1996 Prison 
? Selection method
Both 46/65 (71)
18 Estonia 1994 Two hospitals, pulmonary TB New 61/209 (29)
4 Netherlands 1993–1994 Whole population Both 82/2,594 (3)
19 Gran Canaria, Spain 1991–1992 Whole island ? Both 0/85 (0)
1993 10/179 (5.5)
1994 12/148 (8.1)
1995 18/110 (16)
1996 35/129 (27)
1999 9/40 (23)
USA
9 New Jersey 1996–1998 Whole population Both 68/1,207 (6)
20 Houston, Texas 1994–1999 Whole population ? Both 326/1,283 (25)
Caribbean
21 Cuba, outside Havana 1994–1995 Whole population ? Both 20/157 (13)
22 Guadeloupe 1994–1996 Whole island ? Both 1/95 (1)
22 Martinique 1995–1996 Whole island ? Both 0/31 (0)
South America
22 French Guiana 1995–1996 Whole country ? Both 0/76 (0)
aN/N, number with Beijing strain/ total number of patients; ?, not clear from report.
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In many studies, some culture-positive specimens are not
typed because they are nonviable. IS6110 RFLP typing relies
on large quantities of DNA and hence on viable strains, and
theoretically some genotypes may survive better than others in
vitro. Spoligotyping is PCR-based so does not require viable
isolates, but it is sometimes used only as a secondary method
in specimens that have already been typed by IS6110 RFLP. 
Associations with drug resistance were variable (Table 3):
of the 12 studies with data available, only 4 found statistically
significant increases in the proportions of drug resistance
among those with Beijing strains. Of the Asian studies, only
one found a statistically significant increase in drug resistance
in Beijing strains (14), and in Hong Kong the Beijing strains
were less likely than the others to be isoniazid resistant (13). In
contrast, Beijing strains were strongly associated with drug
resistance in New York, Cuba, and Estonia (3,18,21). In New
York, the spread of the W strain, which was mainly nosoco-
mial and institutional, has been attributed in part to drug resis-
tance. Once a strain has become multidrug resistant, treatment
is more complicated so patients may remain infectious for a
longer period. Whether the Beijing family has a particularly
high probability of acquiring drug resistance is not known but
is suggested by the fact that these associations with the same
strain family have been found in widely distributed areas.
The published studies provided little direct evidence that
the Beijing strain has been increasing. Of the two studies that
included time trends, one found no increase in a population
with a very high prevalence for many decades (12), and in the
other the increase may be attributable to the characteristics of
the index patient in the outbreak (19,36). In Vietnam, the pro-
portion of new TB patients with the Beijing strain decreased
with age, suggesting an increase in Beijing strains in the com-
Table 2. Prevalence of Beijing and W-like strains in studies not based on spoligotypinga
Reference Setting Yrs Population
New TB or 
new + old Typing methods and definitions used
Prevalence of 
Beijing strain 
N/N (%)
Asia
23 Henan Province, 
China
? No information given ? RFLP +3.6kb Pvu II fragment 59/64 (92)
23 Philippines ? No information given ? RFLP +3.6kb Pvu II fragment 34/34 (100)
23 Hanoi, Vietnam ? No information given ? RFLP +3.6kb Pvu II fragment 20/50 (40)
23 Korea 1995 No information given ? RFLP +3.6kb Pvu II fragment 99/138 (72)
23 Thailand ? No information given ? RFLP +3.6kb Pvu II fragment 31/49 (63)
24 Bangkok 
Nonthaburi, Thailand
1994–1995 Patients from 3 hospitals ? how 
selected. Half extrapulmonary
? Both RFLP + comparison 
with Dutch database
80/211 (37)
23 Malaysia ? No information given ? RFLP +3.6kb Pvu II fragment 17/48 (35)
25 Malaysia 1993–1994 Random 3% sample from whole 
population
? Both RFLP “similar” to Beijing family 83/439 (19)
Africa
26 Cape Town, South 
Africa
1993–1997 Whole population Both RFLP  “strain U”, (W-like)
Two closely related patterns only
17/650 (2.6)
USA
27 New York City 1992–1994 Patients from 5 hospitals ? Both RFLP, strain W only 6/302 (2.0)
3 New York City 1990–1995 ? selection method ? Both RFLP, “W-like” 273/1,953 (14)
28 Central Los Angeles 1994–1996 Consecutive patients ? Both RFLP, strain 210 (W-related) 43/162 (27)
29 California 1992–1995 All cases from specific locations ? Both RFLP, strain 210 (W-related) 39/522  (7)
29 Texas 1993–1995 All cases from specific locations ? Both RFLP, strain 210 (W-related) 16/546  (3)
29 Colorado 1989–1994 All cases from specific locations ? Both RFLP, strain 210 (W-related) 2/256  (0.8)
2 United States 
(excluding NY) and 
Puerto Rico
1992–1997 All notified cases Both RFLP and/or PCR probe. 
Multidrug resistant W only 
23/104,549 (0.02)
South America
30 Buenaventura, 
Colombia
1997–1998 34 treatment failure + 73 new
? selection method 
Both RFLP + PCR probe. “Similar” to W 11/107 (10)
(? 8 in new)
aN/N, number with Beijing strain/total number of patient; ?, not clear from report; the different typing methods are described in the introduction. RFLP:  restriction fragment length 
polymorphism using IS6110. PCR: Polymerase chain reaction  probe is a multiplex PCR probe targeted at specific insertions. The 3.6 kb pvuII fragment was identified by IS1081 fin-
gerprinting.
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munities studied (14). No association with age was found any-
where else (8,9,13,15,18,19,24), including the two other
studies restricted to new patients (13,18).
On the other hand, the ubiquity of the Beijing strain and its
frequent appearance in outbreaks, particularly of drug-resistant
TB, suggest that it may have the potential to spread. In Esto-
nia, although there was no association between Beijing strains
and age, TB and particularly multidrug-resistant (MDR) TB
have been increasing, and most MDR TB was found to be due
to Beijing strains (18). The limited amount of information
available from most areas of the world and the possible biases
in many of the studies make definite conclusions about the
extent of spread and associations with drug resistance impossi-
ble. Through the European Concerted Action on New Genera-
tion Genetic Markers and Techniques for the Epidemiology
and Control of Tuberculosis, a standard definition of the
Beijing genotype is being finalized, by comparisons of large
collections of strains typed with spoligotyping, IS6110 RFLP,
and Region A RFLP, which visualizes insertion of IS6110 in
the genomic dnaA-dnaN locus (ms. in preparation). Studies
are planned to reanalyze available data worldwide by using
standard definitions and approaches.
Further studies are also needed to include more areas in an
unbiased way, to study historical specimens if possible, and to
investigate the virulence (8) and transmissibility of this poten-
tially important family of M. tuberculosis strains. The question
to be answered is if and to what extent Beijing genotype
strains have selective advantages over other M. tuberculosis
genotypes in the ability to gain resistance and to interact with
the host immune defense system. If Beijing genotype strains
represent a higher level of evolutionary development of M.
tuberculosis being selected for as a result of the introduction of
tuberculostatics, which inhibit the growth of M. tuberculosis,
then consequences for the treatment of tuberculosis will be
serious. 
Table 3. Association between Beijing family strains of Mycobacterium tuberculosis and drug resistancea
Reference Place, yr
Strain
% Drug resistance
Comparison of Beijing 
vs. non-Beijing by drugb
RR  95% CIb 
Any I S MDR
Beijing Non-
Beijing
Beijing Non-
Beijing
Beijing Non-
Beijing
Beijing Non-
Beijing
Beijing Non-
Beijing
13 Hong Kong, 
1998–1999
310 181 6 12 10 13 I  0.54 (0.30 to 0.97)
S 0.76 (0.46 to 1.3)
14 Ho Chi 
Minh City, 
1998–1999
264 235 28 19 42 19 3 2 I 1.5 (1.1 to 2.0)
S 2.2 (1.6 to 3.0)
MDR 1.4 (0.47 to 4.3)
15 Bangkok, 
1999–2000
90 114 No assoc
8 Jakarta, 
1998–1999
27 56 41 25 37 20 15 5 Any 1.6 (0.86 to 3.1)
I 1.9 (0.92 to 3.9)
S 2.8 (0.67 to 11.5)
16 Senegal, 
1994–1995
8 61 No assoc
11 NW Russia, 
1997–1998
22 78 77 58 MDR 1.3 (1.0 to 1.8)
10 Azerbaijan, 
1995–1996
46 19 89 68 80 68 83 58 61 32 Any 1.3 (0.94 to 1.8)
I 1.2 (0.84 to 1.6)
S 1.4 (0.95 to 2.1)
MDR 1.9 (0.96 to 3.9)
18 Estonia, 
1994
61 148 70 14 34 2 Any 5.0 (3.2 to 7.6)
MDR 17.0 (5.3 to 54.9)
19 Gran 
Canaria, 
1991–1996
75 576 0 ?
3 New York, 
1990–1995
273 
(W-
like)
1,680 
(not W 
like)
93c ?0 p <0.001
21d Cuba, 
1994–1995
20 137 55–65 4–5 55–60 4 0–10 0.7–2 0 0.7 Any 10.8 (4.7  to 24.5)
I 15.1 (5.8 to 38.9)
30 Colombia, 
1997–1998
11 70 27 23 MDR 1.2 (0.41 to 3.4)
aI, isoniazid; S, streptomycin; MDR, multidrug resistant (at least isoniazid and rifampicin); blank spaces indicate that data are not available.
bRelative risks (RR) were calculated when possible from the data presented. These are shown with 95% confidence intervals.
c Resistant to at least four drugs. Includes 206 W strains and 40 W1 strains. Identified by RFLP, not spoligotyping. 
dExact numbers not clear since drug resistance data only given by strain number for IS6110 defined clusters, and two Beijing strains were not clustered. For the relative risk calculation, 
the minimum proportion resistant among the Beijing strains was used.
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